Integral Ad Science (IAS) Financials

$8.06 +0.18 (+2.22%)

As of 12:53 PM Eastern

Annual Income Statements for Integral Ad Science

This table shows Integral Ad Science's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Income / (Loss) Attributable to Common Shareholders	38	7.24	15	-52	-32	-51
Consolidated Net Income / (Loss)	38	7.24	15	-52	-32	-51
Net Income / (Loss) Continuing Operations	38	7.24	15	-52	-32	-51
Total Pre-Tax Income	55	4.86	13	-56	-45	-67
Total Operating Income	60	17	15	-33	-14	-34
Total Gross Profit	416	375	340	269	200	180
Total Revenue	530	474	415	324	241	213
Operating Revenue	530	474	415	324	241	213
Total Cost of Revenue	114	99	76	55	41	33
Operating Cost of Revenue	114	99	76	55	41	33
Total Operating Expenses	356	358	317	302	214	214
Selling, General & Admin Expense	96	112	80	79	33	32
Marketing Expense	122	118	106	86	66	71
Research & Development Expense	70	73	76	67	49	40
Depreciation Expense	64	55	50	62	66	70
Other Operating Expenses / (Income)	3.93	0.43	4.75	0.65	0.64	-
Total Other Income / (Expense), net	-5.36	-12	-9.05	-23	-32	-33
Interest & Investment Income	-5.36	-12	-9.05	-	-32	-
Income Tax Expense	17	-2.38	-2.29	-3.54	-13	-15
Basic Earnings per Share	$0.23	$0.05	$0.10	($0.37)	($0.24)	($0.39)
Weighted Average Basic Shares Outstanding	161.06M	156.27M	154.70M	143.54M	134.04M	131.61M
Diluted Earnings per Share	$0.23	$0.04	$0.10	($0.37)	($0.24)	($0.39)
Weighted Average Diluted Shares Outstanding	165.47M	161.72M	157.26M	143.54M	134.04M	131.61M
Weighted Average Basic & Diluted Shares Outstanding	163.80M	159.52M	154.42M	154.44M	-	-

This table shows Integral Ad Science's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	15	16	7.69	-1.26	10	-14	7.68	3.15	11	0.77
Consolidated Net Income / (Loss)	15	16	7.69	-1.26	10	-14	7.68	3.15	11	0.77
Net Income / (Loss) Continuing Operations	15	16	7.69	-1.26	10	-14	7.68	3.15	11	0.77
Total Pre-Tax Income	25	19	13	-1.39	14	6.09	-21	6.17	4.12	2.05
Total Operating Income	26	20	14	0.54	17	9.20	-18	9.59	7.31	-2.31
Total Gross Profit	120	106	102	88	106	95	90	84	96	89
Total Revenue	153	134	129	115	134	120	114	106	117	108
Operating Revenue	153	134	129	115	134	120	114	106	117	108
Total Cost of Revenue	33	27	27	26	28	26	24	22	22	19
Operating Cost of Revenue	33	27	27	26	28	26	24	22	22	19
Total Operating Expenses	94	86	88	88	90	86	108	75	88	84
Selling, General & Admin Expense	24	25	25	21	26	23	42	21	24	20
Marketing Expense	31	30	30	32	30	30	32	26	28	28
Research & Development Expense	18	17	17	18	19	17	21	16	22	19
Depreciation Expense	17	16	16	15	15	14	14	13	13	13
Other Operating Expenses / (Income)	4.65	-2.61	0.32	1.57	-0.50	2.08	-0.63	-0.52	1.25	4.06
Total Other Income / (Expense), net	-0.57	-1.33	-1.54	-1.93	-2.49	-3.11	-3.22	-3.42	-3.19	-2.62
Income Tax Expense	9.67	2.77	4.92	-0.13	3.86	20	-29	3.03	-7.37	1.29
Basic Earnings per Share	$0.09	$0.10	$0.05	($0.01)	$0.07	($0.09)	$0.05	$0.02	$0.08	$0.00
Weighted Average Basic Shares Outstanding	161.06M	161.66M	160.50M	159.39M	156.27M	157.06M	155.43M	154.32M	154.70M	155.39M
Diluted Earnings per Share	$0.09	$0.10	$0.05	($0.01)	$0.06	($0.09)	$0.05	$0.02	$0.08	$0.00
Weighted Average Diluted Shares Outstanding	165.47M	165.08M	163.75M	159.39M	161.72M	157.06M	162.63M	157.88M	157.26M	156.70M
Weighted Average Basic & Diluted Shares Outstanding	163.80M	162.67M	161.36M	160.54M	159.52M	157.85M	156.65M	154.93M	154.42M	153.83M

This table details how cash moves in and out of Integral Ad Science's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Change in Cash & Equivalents	-39	38	17	24	23	-13
Net Cash From Operating Activities	118	132	72	64	34	-1.85
Net Cash From Continuing Operating Activities	118	132	72	64	34	-1.85
Net Income / (Loss) Continuing Operations	38	7.24	15	-52	-32	-51
Consolidated Net Income / (Loss)	38	7.24	15	-52	-32	-51
Depreciation Expense	64	55	50	62	66	70
Amortization Expense	0.46	0.46	0.46	1.14	1.37	1.27
Non-Cash Adjustments To Reconcile Net Income	55	80	39	64	2.76	3.22
Changes in Operating Assets and Liabilities, net	-40	-11	-33	-12	-3.53	-25
Net Cash From Investing Activities	-41	-35	-18	-200	-9.66	-25
Net Cash From Continuing Investing Activities	-41	-35	-18	-200	-9.66	-25
Purchase of Property, Plant & Equipment	-41	-34	-17	-14	-9.66	-7.46
Acquisitions	0.00	-0.97	-1.60	-186	0.00	-18
Net Cash From Financing Activities	-116	-59	-37	160	-1.70	14
Net Cash From Continuing Financing Activities	-116	-59	-37	160	-1.70	14
Repayment of Debt	-120	-145	-37	-359	-1.53	-3.18
Repurchase of Common Equity	0.00	0.00	-24	-8.43	-0.17	-3.17
Issuance of Debt	0.00	75	15	245	0.00	20
Issuance of Common Equity	3.21	3.16	0.85	282	0.00	0.00
Other Financing Activities, net	0.41	7.99	7.16	1.08	0.00	0.00
Cash Interest Paid	4.90	11	8.51	17	21	28
Cash Income Taxes Paid	35	11	16	2.24	1.42	1.16

This table details how cash moves in and out of Integral Ad Science's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	29	-15	-13	-40	32	-5.29	4.21	7.52	11	-0.62
Net Cash From Operating Activities	68	25	26	-1.13	58	22	29	23	25	24
Net Cash From Continuing Operating Activities	66	27	26	-1.13	57	22	29	23	25	24
Net Income / (Loss) Continuing Operations	15	16	7.69	-1.26	10	-14	7.68	3.15	11	0.77
Consolidated Net Income / (Loss)	15	16	7.69	-1.26	10	-14	7.68	3.15	11	0.77
Depreciation Expense	17	16	16	15	15	14	14	13	13	13
Amortization Expense	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12
Non-Cash Adjustments To Reconcile Net Income	10	11	14	20	11	14	42	12	9.59	8.73
Changes in Operating Assets and Liabilities, net	23	-16	-12	-35	21	7.62	-34	-5.57	-9.10	2.13
Net Cash From Investing Activities	-10	-10	-9.87	-10	-9.23	-8.76	-8.40	-8.34	-5.82	-4.28
Net Cash From Continuing Investing Activities	-9.07	-11	-9.87	-10	-9.23	-8.76	-8.40	-8.34	-5.82	-4.28
Purchase of Property, Plant & Equipment	-9.07	-11	-9.87	-10	-8.26	-8.76	-8.40	-8.34	-5.82	-4.29
Net Cash From Financing Activities	-29	-30	-29	-28	-17	-19	-17	-7.10	-8.28	-21
Net Cash From Continuing Financing Activities	-29	-30	-29	-28	-17	-19	-17	-7.10	-8.28	-21
Repayment of Debt	-30	-30	-30	-30	-20	-20	-20	-85	-9.98	-15
Issuance of Common Equity	0.88	0.12	0.82	1.39	0.92	0.83	0.62	0.79	0.46	0.39
Other Financing Activities, net	0.10	-	-	0.31	2.41	0.59	2.88	2.12	1.25	2.53
Cash Interest Paid	0.29	1.00	1.74	1.88	2.35	3.02	2.86	3.00	2.96	2.52
Cash Income Taxes Paid	4.86	10	20	0.27	0.62	4.75	4.67	0.94	4.58	1.72

This table presents Integral Ad Science's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Total Assets	1,152	1,192	1,169	1,130	850
Total Current Assets	254	265	221	170	130
Cash & Equivalents	84	125	87	73	52
Restricted Cash	0.51	0.05	0.05	0.07	0.19
Accounts Receivable	133	121	109	89	74
Prepaid Expenses	37	19	25	7.63	4.10
Plant, Property, & Equipment, net	4.00	3.77	2.41	1.41	2.24
Total Noncurrent Assets	893	923	945	958	718
Goodwill	673	675	674	677	459
Intangible Assets	195	219	241	276	256
Noncurrent Deferred & Refundable Income Taxes	1.68	2.47	2.02	0.89	0.00
Other Noncurrent Operating Assets	24	26	28	4.14	3.56
Total Liabilities & Shareholders' Equity	1,152	1,192	1,169	1,130	850
Total Liabilities	144	282	360	362	418
Total Current Liabilities	84	82	68	56	40
Accounts Payable	73	72	61	56	39
Current Deferred Revenue	1.06	0.68	0.10	0.16	1.14
Other Current Liabilities	10	9.56	6.87	0.00	-
Total Noncurrent Liabilities	59	200	293	306	378
Long-Term Debt	34	154	223	243	351
Capital Lease Obligations	13	20	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	3.12	20	45	54	25
Other Noncurrent Operating Liabilities	8.71	6.18	24	8.68	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,008	909	808	767	431
Total Preferred & Common Equity	1,008	909	808	767	0.00
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,008	909	808	767	431
Common Stock	965	901	810	782	554
Retained Earnings	47	8.95	0.78	-15	-127
Accumulated Other Comprehensive Income / (Loss)	-3.67	-0.92	-2.90	-0.32	4.52

This table presents Integral Ad Science's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,135	1,144	1,146	1,170	1,162	1,161	1,133
Total Current Assets	225	230	228	240	223	219	188
Cash & Equivalents	57	71	84	92	99	94	74
Restricted Cash	0.17	0.28	0.30	0.13	0.07	0.31	0.14
Accounts Receivable	130	121	111	129	113	103	93
Prepaid Expenses	38	38	32	19	12	21	21
Plant, Property, & Equipment, net	4.08	4.08	4.09	3.51	3.84	3.87	1.59
Total Noncurrent Assets	906	910	914	927	935	938	944
Goodwill	676	674	674	674	675	675	671
Intangible Assets	202	207	213	224	230	236	248
Noncurrent Deferred & Refundable Income Taxes	2.54	2.44	2.43	1.67	1.74	1.72	0.81
Other Noncurrent Operating Assets	26	26	24	27	28	26	23
Total Liabilities & Shareholders' Equity	1,135	1,144	1,146	1,170	1,162	1,161	1,133
Total Liabilities	152	197	221	292	284	334	358
Total Current Liabilities	61	61	53	69	59	55	51
Short-Term Debt	10	9.48	9.12	-	-	-	-
Accounts Payable	49	51	42	60	50	48	44
Current Deferred Revenue	1.45	0.56	1.32	0.24	0.43	0.62	0.29
Other Current Liabilities	0.00	0.00	0.08	9.07	8.00	6.39	6.86
Total Noncurrent Liabilities	92	135	168	223	225	279	307
Long-Term Debt	64	94	124	174	193	213	233
Capital Lease Obligations	16	18	18	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	4.99	17	20	24	7.97	43	53
Other Noncurrent Operating Liabilities	6.19	6.17	6.17	25	24	23	21
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	982	948	925	879	878	828	775
Total Preferred & Common Equity	982	948	925	879	878	828	775
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	982	948	925	879	878	828	775
Common Stock	952	934	919	884	868	825	797
Retained Earnings	31	15	7.70	-1.21	13	4.86	-11
Accumulated Other Comprehensive Income / (Loss)	-1.28	-2.17	-1.98	-3.69	-1.97	-1.75	-12

This table displays calculated financial ratios and metrics derived from Integral Ad Science's official financial filings.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Growth Metrics	-	-	-	-	-	-
Revenue Growth	11.75%	14.22%	28.38%	34.44%	12.72%	0.00%
EBITDA Growth	72.11%	9.85%	117.08%	-42.83%	40.67%	0.00%
EBIT Growth	253.30%	12.77%	145.92%	-137.82%	58.92%	0.00%
NOPAT Growth	62.80%	43.07%	177.06%	-137.82%	58.92%	0.00%
Net Income Growth	422.17%	-52.92%	129.32%	-61.97%	36.95%	0.00%
EPS Growth	475.00%	-60.00%	127.03%	-54.17%	38.46%	0.00%
Operating Cash Flow Growth	-10.43%	81.63%	13.95%	87.39%	1,930.47%	0.00%
Free Cash Flow Firm Growth	136.94%	21.91%	104.35%	69.10%	0.00%	0.00%
Invested Capital Growth	1.33%	1.41%	0.84%	28.15%	0.00%	0.00%
Revenue Q/Q Growth	3.67%	3.69%	3.74%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	10.00%	17.85%	8.32%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	17.52%	116.63%	165.59%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	8.92%	361.27%	1,923.76%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	15.62%	-15.44%	1,744.17%	0.00%	0.00%	0.00%
EPS Q/Q Growth	15.00%	-33.33%	1,100.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	9.41%	32.92%	-1.40%	15.77%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	260.01%	161.28%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-4.46%	-0.21%	1.07%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	78.50%	79.06%	81.76%	83.13%	83.17%	84.49%
EBITDA Margin	23.55%	15.29%	15.90%	9.40%	22.11%	17.71%
Operating Margin	11.39%	3.60%	3.65%	-10.20%	-5.77%	-15.83%
EBIT Margin	11.39%	3.60%	3.65%	-10.20%	-5.77%	-15.83%
Profit (Net Income) Margin	7.13%	1.53%	3.70%	-16.21%	-13.45%	-24.05%
Tax Burden Percent	68.68%	149.05%	117.49%	93.68%	71.23%	76.89%
Interest Burden Percent	91.13%	28.41%	86.33%	169.57%	327.45%	197.66%
Effective Tax Rate	31.32%	-49.05%	-17.49%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	4.30%	2.68%	1.89%	-2.77%	-2.66%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-62.47%	-17.06%	0.30%	-15.28%	-17.79%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-0.36%	-1.84%	0.06%	-5.98%	-12.35%	0.00%
Return on Equity (ROE)	3.94%	0.84%	1.95%	-8.75%	-15.01%	0.00%
Cash Return on Invested Capital (CROIC)	2.98%	1.28%	1.06%	-27.45%	-202.66%	0.00%
Operating Return on Assets (OROA)	5.15%	1.45%	1.32%	-3.34%	-1.63%	0.00%
Return on Assets (ROA)	3.23%	0.61%	1.34%	-5.30%	-3.81%	0.00%
Return on Common Equity (ROCE)	3.94%	0.84%	1.95%	-8.75%	-15.01%	0.00%
Return on Equity Simple (ROE_SIMPLE)	3.75%	0.80%	1.90%	-6.83%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	41	25	18	-23	-9.72	-24
NOPAT Margin	7.82%	5.37%	4.29%	-7.14%	-4.04%	-11.08%
Net Nonoperating Expense Percent (NNEP)	66.77%	19.74%	1.59%	12.51%	15.13%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	3.93%	2.35%	1.73%	-	-	-
Cost of Revenue to Revenue	21.50%	20.94%	18.24%	16.87%	16.83%	15.51%
SG&A Expenses to Revenue	18.06%	23.53%	19.18%	24.42%	13.68%	15.05%
R&D to Revenue	13.18%	15.37%	18.38%	20.72%	20.36%	18.93%
Operating Expenses to Revenue	67.11%	75.45%	76.43%	93.34%	88.94%	100.32%
Earnings before Interest and Taxes (EBIT)	60	17	15	-33	-14	-34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	125	73	66	30	53	38
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	1.68	2.50	1.67	4.46	0.63	0.00
Price to Tangible Book Value (P/TBV)	12.10	151.79	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.20	4.79	3.26	10.57	1.12	1.26
Price to Earnings (P/E)	44.93	313.83	87.96	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.23%	0.32%	1.14%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.71	2.42	1.58	3.83	0.78	0.00
Enterprise Value to Revenue (EV/Rev)	3.13	4.89	3.58	11.09	2.37	0.00
Enterprise Value to EBITDA (EV/EBITDA)	13.31	31.99	22.55	118.00	10.71	0.00
Enterprise Value to EBIT (EV/EBIT)	27.50	135.73	98.20	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	40.05	91.06	83.59	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.09	17.63	20.54	56.43	16.78	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	57.74	191.08	149.46	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.05	0.19	0.28	0.32	0.81	0.00
Long-Term Debt to Equity	0.05	0.19	0.28	0.32	0.81	0.00
Financial Leverage	0.01	0.11	0.19	0.39	0.69	0.00
Leverage Ratio	1.22	1.37	1.46	1.65	1.97	0.00
Compound Leverage Factor	1.11	0.39	1.26	2.80	6.45	0.00
Debt to Total Capital	4.51%	16.00%	21.64%	24.04%	44.89%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.04%	0.00%
Long-Term Debt to Total Capital	4.51%	16.00%	21.64%	24.04%	44.84%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	95.49%	84.00%	78.36%	75.96%	55.11%	0.00%
Debt to EBITDA	0.38	2.39	3.38	7.98	6.61	0.00
Net Debt to EBITDA	-0.30	0.67	2.07	5.57	5.63	0.00
Long-Term Debt to EBITDA	0.38	2.39	3.38	7.98	6.60	0.00
Debt to NOPAT	1.15	6.80	12.54	-10.51	-36.17	0.00
Net Debt to NOPAT	-0.90	1.90	7.66	-7.34	-30.82	0.00
Long-Term Debt to NOPAT	1.15	6.80	12.54	-10.51	-36.13	0.00
Altman Z-Score	7.97	5.47	2.81	5.95	0.53	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	3.02	3.21	3.26	3.01	3.21	0.00
Quick Ratio	2.58	2.98	2.90	2.88	3.10	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	29	12	9.96	-229	-741	0.00
Operating Cash Flow to CapEx	290.79%	389.97%	434.22%	465.66%	351.24%	-24.86%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-9.97	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	2.77	0.00	-0.06
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	2.17	0.00	-0.28
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.45	0.40	0.36	0.33	0.28	0.00
Accounts Receivable Turnover	4.17	4.11	4.18	3.98	3.27	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	136.40	153.49	217.17	176.98	107.28	0.00
Accounts Payable Turnover	1.57	1.49	1.29	1.15	1.04	0.00
Days Sales Outstanding (DSO)	87.45	88.72	87.32	91.81	111.49	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	232.44	244.37	282.18	318.60	350.88	0.00
Cash Conversion Cycle (CCC)	-144.99	-155.64	-194.86	-226.79	-239.39	0.00
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	971	958	945	937	731	0.00
Invested Capital Turnover	0.55	0.50	0.44	0.39	0.66	0.00
Increase / (Decrease) in Invested Capital	13	13	7.85	206	731	0.00
Enterprise Value (EV)	1,661	2,320	1,488	3,589	569	0.00
Market Capitalization	1,698	2,271	1,352	3,419	270	270
Book Value per Share	$6.20	$5.76	$5.25	$4.98	$3.22	$0.00
Tangible Book Value per Share	$0.86	$0.09	($0.70)	($1.21)	($2.11)	$0.00
Total Capital	1,056	1,083	1,031	1,010	783	0.00
Total Debt	48	173	223	243	351	0.00
Total Long-Term Debt	48	173	223	243	351	0.00
Net Debt	-37	48	136	170	299	0.00
Capital Expenditures (CapEx)	41	34	17	14	9.66	7.46
Debt-free, Cash-free Net Working Capital (DFCFNWC)	85	58	66	40	38	0.00
Debt-free Net Working Capital (DFNWC)	170	182	153	114	89	0.00
Net Working Capital (NWC)	170	182	153	114	89	0.00
Net Nonoperating Expense (NNE)	3.68	18	2.43	29	23	28
Net Nonoperating Obligations (NNO)	-37	48	136	170	299	0.00
Total Depreciation and Amortization (D&A)	64	55	51	63	67	72
Debt-free, Cash-free Net Working Capital to Revenue	16.09%	12.15%	16.00%	12.49%	15.59%	0.00%
Debt-free Net Working Capital to Revenue	32.12%	38.46%	36.93%	35.14%	37.17%	0.00%
Net Working Capital to Revenue	32.12%	38.46%	36.93%	35.14%	37.03%	0.00%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.23	$0.05	$0.10	($0.37)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	161.06M	156.27M	154.70M	143.54M	0.00	0.00
Adjusted Diluted Earnings per Share	$0.23	$0.04	$0.10	($0.37)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	165.47M	161.72M	157.26M	143.54M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	163.80M	159.52M	154.42M	154.44M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	41	12	11	-18	-9.72	-24
Normalized NOPAT Margin	7.82%	2.52%	2.55%	-5.71%	-4.04%	-11.08%
Pre Tax Income Margin	10.38%	1.02%	3.15%	-17.30%	-18.89%	-31.28%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	-1.44	0.00	-1.02
NOPAT to Interest Expense	0.00	0.00	0.00	-1.01	0.00	-0.72
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-2.03	0.00	-1.25
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-1.60	0.00	-0.94
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	153.87%	-16.08%	-0.52%	-6.17%

This table displays calculated financial ratios and metrics derived from Integral Ad Science's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	13.96%	10.97%	13.51%	7.95%	14.36%	11.08%	13.28%	18.88%	14.60%	37.09%
EBITDA Growth	36.34%	56.55%	755.60%	-30.17%	54.27%	123.92%	-123.60%	40.95%	33.46%	-31.56%
EBIT Growth	54.52%	119.40%	177.70%	-94.40%	125.90%	498.66%	-369.92%	181.20%	441.38%	-91.69%
NOPAT Growth	30.52%	182.92%	167.68%	-92.31%	-41.34%	-2,309.44%	-575.21%	145.36%	1,461.26%	-2.26%
Net Income Growth	50.25%	217.02%	0.17%	-139.89%	-11.51%	-1,892.57%	291.48%	171.44%	338.20%	107.84%
EPS Growth	50.00%	211.11%	0.00%	-150.00%	-25.00%	0.00%	400.00%	100.00%	366.67%	100.00%
Operating Cash Flow Growth	17.64%	15.40%	-10.91%	-104.93%	130.88%	-9.46%	142.22%	105.20%	-3.98%	429.46%
Free Cash Flow Firm Growth	313.09%	15.76%	62.52%	-1,443.35%	-110.89%	-253.80%	79.73%	99.69%	0.00%	98.59%
Invested Capital Growth	1.33%	5.84%	2.64%	4.76%	1.41%	2.71%	3.49%	0.83%	0.84%	1.32%
Revenue Q/Q Growth	14.61%	3.51%	12.64%	-14.72%	11.60%	5.88%	7.12%	-9.66%	8.41%	7.97%
EBITDA Q/Q Growth	16.46%	21.93%	90.52%	-49.60%	33.73%	610.59%	-120.29%	11.34%	94.11%	-46.19%
EBIT Q/Q Growth	26.38%	42.67%	2,534.82%	-96.75%	79.45%	150.53%	-289.89%	31.19%	416.68%	-134.21%
NOPAT Q/Q Growth	-9.28%	99.61%	2,194.89%	-96.86%	157.63%	-62.92%	-360.78%	-76.04%	2,467.15%	-132.13%
Net Income Q/Q Growth	-5.08%	109.22%	712.75%	-112.35%	173.93%	-279.09%	144.02%	-72.61%	1,397.52%	-60.89%
EPS Q/Q Growth	-10.00%	100.00%	600.00%	-116.67%	166.67%	-280.00%	150.00%	-75.00%	0.00%	-100.00%
Operating Cash Flow Q/Q Growth	165.83%	-1.87%	2,392.93%	-101.97%	160.77%	-24.25%	26.81%	-7.83%	2.27%	102.65%
Free Cash Flow Firm Q/Q Growth	107.50%	-127.52%	61.82%	-313.96%	97.04%	-1.23%	-1,471.93%	-123.08%	196.33%	94.20%
Invested Capital Q/Q Growth	-4.46%	1.74%	0.71%	2.50%	-0.21%	-1.33%	2.79%	0.20%	1.07%	-0.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	78.22%	79.50%	79.00%	77.16%	78.96%	78.73%	79.04%	79.56%	81.36%	82.30%
EBITDA Margin	27.81%	27.37%	23.23%	13.74%	23.25%	19.40%	-4.02%	21.24%	17.23%	9.62%
Operating Margin	16.67%	15.12%	10.97%	0.47%	12.29%	7.65%	-16.02%	9.04%	6.22%	-2.13%
EBIT Margin	16.67%	15.12%	10.97%	0.47%	12.29%	7.65%	-16.02%	9.04%	6.22%	-2.13%
Profit (Net Income) Margin	9.98%	12.05%	5.96%	-1.10%	7.57%	-11.43%	6.75%	2.97%	9.78%	0.71%
Tax Burden Percent	61.23%	85.30%	60.97%	90.35%	72.49%	-225.69%	-35.82%	50.97%	279.13%	37.34%
Interest Burden Percent	97.76%	93.44%	89.14%	-258.66%	84.93%	66.21%	117.69%	64.37%	56.30%	-88.99%
Effective Tax Rate	38.77%	14.70%	39.03%	0.00%	27.51%	325.69%	0.00%	49.03%	-179.13%	62.66%
Return on Invested Capital (ROIC)	5.61%	6.68%	3.38%	0.16%	4.44%	-8.34%	-5.22%	2.11%	7.67%	-0.34%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.73%	4.70%	2.09%	-1.60%	2.49%	-2.50%	11.11%	0.87%	1.84%	0.65%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.29%	0.17%	-0.17%	0.27%	-0.36%	1.67%	0.15%	0.36%	0.14%
Return on Equity (ROE)	5.61%	6.96%	3.55%	-0.01%	4.71%	-8.70%	-3.55%	2.26%	8.03%	-0.20%
Cash Return on Invested Capital (CROIC)	2.98%	-1.82%	-2.23%	-4.07%	1.28%	-2.09%	-3.69%	1.45%	1.06%	0.00%
Operating Return on Assets (OROA)	7.54%	6.71%	4.74%	0.20%	4.94%	3.04%	-6.20%	3.38%	2.25%	-0.77%
Return on Assets (ROA)	4.51%	5.35%	2.58%	-0.46%	3.04%	-4.54%	2.61%	1.11%	3.54%	0.26%
Return on Common Equity (ROCE)	5.61%	6.96%	3.55%	-0.01%	4.71%	-8.70%	-3.55%	2.26%	8.03%	-0.20%
Return on Equity Simple (ROE_SIMPLE)	0.00%	3.33%	0.30%	0.31%	0.00%	0.97%	2.63%	2.10%	0.00%	-0.12%
Net Operating Profit after Tax (NOPAT)	16	17	8.63	0.38	12	-21	-13	4.89	20	-0.86
NOPAT Margin	10.21%	12.90%	6.69%	0.33%	8.91%	-17.26%	-11.22%	4.61%	17.37%	-0.80%
Net Nonoperating Expense Percent (NNEP)	6.34%	1.97%	1.29%	1.76%	1.95%	-5.83%	-16.33%	1.25%	5.83%	-0.99%
Return On Investment Capital (ROIC_SIMPLE)	1.48%	-	-	-	1.11%	-	-	-	1.98%	-
Cost of Revenue to Revenue	21.78%	20.50%	21.00%	22.84%	21.04%	21.27%	20.96%	20.44%	18.64%	17.70%
SG&A Expenses to Revenue	15.88%	18.98%	19.13%	18.67%	19.33%	18.79%	37.25%	19.53%	20.07%	18.60%
R&D to Revenue	11.47%	12.61%	13.56%	15.70%	14.19%	14.30%	18.57%	14.64%	18.97%	17.96%
Operating Expenses to Revenue	61.55%	64.38%	68.03%	76.69%	66.67%	71.08%	95.06%	70.52%	75.14%	77.99%
Earnings before Interest and Taxes (EBIT)	26	20	14	0.54	17	9.20	-18	9.59	7.31	-2.31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	43	37	30	16	31	23	-4.57	23	20	10
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.68	1.78	1.65	1.70	2.50	2.12	3.17	2.66	1.67	1.45
Price to Tangible Book Value (P/TBV)	12.10	16.65	23.71	41.88	151.79	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.20	3.41	3.13	3.26	4.79	4.07	6.25	5.10	3.26	2.82
Price to Earnings (P/E)	44.93	53.36	547.54	554.73	313.83	217.59	120.71	126.93	87.96	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.23%	1.87%	0.18%	0.18%	0.32%	0.46%	0.83%	0.79%	1.14%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.71	1.75	1.61	1.65	2.42	2.03	2.96	2.45	1.58	1.38
Enterprise Value to Revenue (EV/Rev)	3.13	3.48	3.23	3.40	4.89	4.25	6.47	5.37	3.58	3.21
Enterprise Value to EBITDA (EV/EBITDA)	13.31	15.67	16.07	24.96	31.99	31.59	59.24	32.00	22.55	21.12
Enterprise Value to EBIT (EV/EBIT)	27.50	34.60	39.89	204.00	135.73	246.36	0.00	108.84	98.20	225.51
Enterprise Value to NOPAT (EV/NOPAT)	40.05	46.69	438.61	291.43	91.06	351.95	0.00	108.29	83.59	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.09	16.50	15.44	15.25	17.63	19.63	28.42	27.57	20.54	17.51
Enterprise Value to Free Cash Flow (EV/FCFF)	57.74	0.00	0.00	0.00	191.08	0.00	0.00	170.02	149.46	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.05	0.09	0.13	0.16	0.19	0.20	0.22	0.26	0.28	0.30
Long-Term Debt to Equity	0.05	0.08	0.12	0.15	0.19	0.20	0.22	0.26	0.28	0.30
Financial Leverage	0.01	0.06	0.08	0.11	0.11	0.15	0.15	0.17	0.19	0.21
Leverage Ratio	1.22	1.24	1.26	1.32	1.37	1.39	1.39	1.44	1.46	1.45
Compound Leverage Factor	1.19	1.16	1.13	-3.40	1.17	0.92	1.63	0.93	0.82	-1.29
Debt to Total Capital	4.51%	8.45%	11.39%	14.01%	16.00%	16.50%	18.05%	20.49%	21.64%	23.12%
Short-Term Debt to Total Capital	0.00%	0.95%	0.89%	0.85%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	4.51%	7.50%	10.51%	13.16%	16.00%	16.50%	18.05%	20.49%	21.64%	23.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	95.49%	91.55%	88.61%	85.99%	84.00%	83.50%	81.95%	79.51%	78.36%	76.88%
Debt to EBITDA	0.38	0.80	1.22	2.29	2.39	2.82	3.98	2.94	3.38	3.83
Net Debt to EBITDA	-0.30	0.29	0.51	1.01	0.67	1.32	1.95	1.64	2.07	2.61
Long-Term Debt to EBITDA	0.38	0.71	1.12	2.15	2.39	2.82	3.98	2.94	3.38	3.83
Debt to NOPAT	1.15	2.38	33.16	26.77	6.80	31.43	-76.38	9.95	12.54	-238.78
Net Debt to NOPAT	-0.90	0.88	13.87	11.80	1.90	14.71	-37.35	5.53	7.66	-163.21
Long-Term Debt to NOPAT	1.15	2.11	30.58	25.15	6.80	31.43	-76.38	9.95	12.54	-238.78
Altman Z-Score	7.87	7.60	5.44	4.89	5.47	4.42	6.41	4.54	2.79	2.37
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.02	3.71	3.76	4.32	3.21	3.47	3.80	4.01	3.26	3.67
Quick Ratio	2.58	3.08	3.13	3.70	2.98	3.20	3.60	3.61	2.90	3.26
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2.91	-39	-17	-45	-1.37	-46	-46	-2.90	13	-13
Operating Cash Flow to CapEx	745.93%	224.89%	262.80%	-10.99%	696.27%	251.88%	346.71%	275.19%	427.96%	568.38%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-23.22	0.00	0.00	0.00	-0.85	0.00	-4.98
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	-0.59	0.00	0.00	0.00	6.72	0.00	9.30
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	-5.93	0.00	0.00	0.00	4.28	0.00	7.66
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.45	0.44	0.43	0.42	0.40	0.40	0.39	0.37	0.36	0.36
Accounts Receivable Turnover	4.17	3.96	4.27	4.51	4.11	4.12	4.31	4.49	4.18	4.82
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	136.40	134.87	125.91	121.32	153.49	179.52	164.39	164.67	217.17	266.20
Accounts Payable Turnover	1.57	2.00	2.11	2.31	1.49	1.79	1.88	1.69	1.29	1.61
Days Sales Outstanding (DSO)	87.45	92.13	85.44	80.93	88.72	88.51	84.77	81.35	87.32	75.69
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	232.44	182.07	172.81	157.97	244.37	203.84	194.07	215.45	282.18	226.74
Cash Conversion Cycle (CCC)	-144.99	-89.94	-87.37	-77.04	-155.64	-115.32	-109.30	-134.10	-194.86	-151.05
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	971	1,016	999	991	958	960	973	946	945	935
Invested Capital Turnover	0.55	0.52	0.51	0.50	0.50	0.48	0.47	0.46	0.44	0.43
Increase / (Decrease) in Invested Capital	13	56	26	45	13	25	33	7.79	7.85	12
Enterprise Value (EV)	1,661	1,778	1,611	1,640	2,320	1,944	2,880	2,322	1,488	1,287
Market Capitalization	1,698	1,744	1,560	1,574	2,271	1,863	2,786	2,204	1,352	1,128
Book Value per Share	$6.20	$6.09	$5.90	$5.80	$5.76	$5.61	$5.65	$5.36	$5.25	$4.98
Tangible Book Value per Share	$0.86	$0.65	$0.41	$0.24	$0.09	($0.13)	($0.17)	($0.53)	($0.70)	($0.93)
Total Capital	1,056	1,073	1,069	1,076	1,083	1,052	1,072	1,041	1,031	1,008
Total Debt	48	91	122	151	173	174	193	213	223	233
Total Long-Term Debt	48	80	112	142	173	174	193	213	223	233
Net Debt	-37	33	51	66	48	81	95	119	136	159
Capital Expenditures (CapEx)	9.07	11	9.87	10	8.26	8.76	8.40	8.34	5.82	4.29
Debt-free, Cash-free Net Working Capital (DFCFNWC)	85	117	107	100	58	78	66	70	66	63
Debt-free Net Working Capital (DFNWC)	170	175	178	184	182	171	165	165	153	137
Net Working Capital (NWC)	170	164	169	175	182	171	165	165	153	137
Net Nonoperating Expense (NNE)	0.35	1.13	0.94	1.63	1.80	-7.02	-20	1.74	8.92	-1.63
Net Nonoperating Obligations (NNO)	-37	33	51	66	48	81	95	119	136	159
Total Depreciation and Amortization (D&A)	17	16	16	15	15	14	14	13	13	13
Debt-free, Cash-free Net Working Capital to Revenue	16.09%	22.94%	21.51%	20.68%	12.15%	17.13%	14.74%	16.15%	16.00%	15.71%
Debt-free Net Working Capital to Revenue	32.12%	34.13%	35.74%	38.13%	38.46%	37.32%	36.94%	38.07%	36.93%	34.14%
Net Working Capital to Revenue	32.12%	32.13%	33.83%	36.24%	38.46%	37.32%	36.94%	38.07%	36.93%	34.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.09	$0.10	$0.05	($0.01)	$0.07	($0.09)	$0.05	$0.02	$0.08	$0.00
Adjusted Weighted Average Basic Shares Outstanding	161.06M	161.66M	160.50M	159.39M	156.27M	157.06M	155.43M	154.32M	154.70M	155.39M
Adjusted Diluted Earnings per Share	$0.09	$0.10	$0.05	($0.01)	$0.06	($0.09)	$0.05	$0.02	$0.08	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	165.47M	165.08M	163.75M	159.39M	161.72M	157.06M	162.63M	157.88M	157.26M	156.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	163.80M	162.67M	161.36M	160.54M	159.52M	157.85M	156.65M	154.93M	154.42M	153.83M
Normalized Net Operating Profit after Tax (NOPAT)	16	17	8.63	0.38	12	6.44	-13	4.89	5.12	-1.62
Normalized NOPAT Margin	10.21%	12.90%	6.69%	0.33%	8.91%	5.35%	-11.22%	4.61%	4.36%	-1.49%
Pre Tax Income Margin	16.30%	14.13%	9.78%	-1.21%	10.44%	5.06%	-18.86%	5.82%	3.50%	1.90%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.28	0.00	0.00	0.00	2.81	0.00	-0.88
NOPAT to Interest Expense	0.00	0.00	0.00	0.20	0.00	0.00	0.00	1.43	0.00	-0.33
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-5.06	0.00	0.00	0.00	0.36	0.00	-2.52
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-5.15	0.00	0.00	0.00	-1.01	0.00	-1.97
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	153.87%	-2,797.75%

Frequently Asked Questions About Integral Ad Science's Financials

When does Integral Ad Science's fiscal year end?

According to the most recent income statement we have on file, Integral Ad Science's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Integral Ad Science's net income changed over the last 5 years?

Integral Ad Science's net income appears to be on a downward trend, with a most recent value of $37.80 million in 2024, falling from -$51.35 million in 2019. The previous period was $7.24 million in 2023. Find out what analysts predict for Integral Ad Science in the coming months.

What is Integral Ad Science's operating income?

Integral Ad Science's total operating income in 2024 was $60.39 million, based on the following breakdown:

Total Gross Profit: $416.14 million
Total Operating Expenses: $355.76 million

How has Integral Ad Science revenue changed over the last 5 years?

Over the last 5 years, Integral Ad Science's total revenue changed from $213.49 million in 2019 to $530.10 million in 2024, a change of 148.3%.

How much debt does Integral Ad Science have?

Integral Ad Science's total liabilities were at $143.56 million at the end of 2024, a 49.1% decrease from 2023, and a 65.7% decrease since 2020.

How much cash does Integral Ad Science have?

In the past 4 years, Integral Ad Science's cash and equivalents has ranged from $51.73 million in 2020 to $124.76 million in 2023, and is currently $84.47 million as of their latest financial filing in 2024.

How has Integral Ad Science's book value per share changed over the last 5 years?

Over the last 5 years, Integral Ad Science's book value per share changed from 0.00 in 2019 to 6.20 in 2024, a change of 619.7%.

Related Companies

This page (NASDAQ:IAS) was last updated on 5/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integral Ad Science (IAS) Financials

Frequently Asked Questions About Integral Ad Science's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integral Ad Science (IAS) Financials

Annual Income Statements for Integral Ad Science

Quarterly Income Statements for Integral Ad Science

Annual Cash Flow Statements for Integral Ad Science

Quarterly Cash Flow Statements for Integral Ad Science

Annual Balance Sheets for Integral Ad Science

Quarterly Balance Sheets for Integral Ad Science

Annual Metrics And Ratios for Integral Ad Science

Quarterly Metrics And Ratios for Integral Ad Science

Frequently Asked Questions About Integral Ad Science's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools